• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从饥饿大鼠获取的肺表面活性物质可增强肺泡巨噬细胞的吞噬作用。

Pulmonary surfactant obtained from starved rats enhances phagocytosis of alveolar macrophages.

作者信息

Sakai K, Ueyama A, Kishino Y

机构信息

Department of Nutrition, School of Medicine, University of Tokushima, Japan.

出版信息

Cell Mol Biol. 1991;37(4):475-80.

PMID:1934019
Abstract

Phagocytic activity of alveolar macrophages (AM) was enhanced by pulmonary surfactant obtained from bronchoalveolar lavage fluid of rats starved for 2 days, as compared to fed. The enhanced activity of phagocytosis was dependent on the dose of surfactant. The prepared surfactant showed a different protein to phospholipid ratio of 0.108 in fed and 0.234 in 2 days starved, because of an increased ratio of protein in surfactant from 2 days starved rats. F(ab')2 anti-surfactant protein inhibited the enhanced AM phagocytosis by surfactant. These results suggested that the enhancement of AM phagocytosis in 2 days starved rats was on account of an increase of protein in their surfactant compared to fed.

摘要

与喂食大鼠相比,从饥饿2天的大鼠支气管肺泡灌洗液中获得的肺表面活性物质可增强肺泡巨噬细胞(AM)的吞噬活性。吞噬活性的增强取决于表面活性物质的剂量。制备的表面活性物质在喂食大鼠中显示出不同的蛋白质与磷脂比率,即0.108,而在饥饿2天的大鼠中为0.234,这是因为饥饿2天大鼠的表面活性物质中蛋白质比率增加。F(ab')2抗表面活性物质蛋白可抑制表面活性物质增强的AM吞噬作用。这些结果表明,与喂食大鼠相比,饥饿2天大鼠的AM吞噬作用增强是由于其表面活性物质中蛋白质增加所致。

相似文献

1
Pulmonary surfactant obtained from starved rats enhances phagocytosis of alveolar macrophages.从饥饿大鼠获取的肺表面活性物质可增强肺泡巨噬细胞的吞噬作用。
Cell Mol Biol. 1991;37(4):475-80.
2
Effects of pulmonary surfactant and surfactant protein A on phagocytosis of fractionated alveolar macrophages: relationship to starvation.肺表面活性物质和表面活性蛋白A对分离的肺泡巨噬细胞吞噬作用的影响:与饥饿的关系。
Cell Mol Biol. 1992 Apr;38(2):123-30.
3
Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages.表面活性蛋白A而非表面活性蛋白D是大鼠肺泡巨噬细胞吞噬甲型流感病毒的调理素。
Eur J Immunol. 1997 Apr;27(4):886-90. doi: 10.1002/eji.1830270413.
4
Lung surfactant protein A (SP-A) enhances serum-independent phagocytosis of bacteria by alveolar macrophages.肺表面活性蛋白A(SP-A)可增强肺泡巨噬细胞对细菌的非血清依赖性吞噬作用。
Eur J Cell Biol. 1992 Feb;57(1):95-100.
5
Effects of surfactant lipids and surfactant protein a on host defense functions of rat alveolar macrophages.表面活性脂质和表面活性蛋白A对大鼠肺泡巨噬细胞宿主防御功能的影响。
Pediatr Res. 2002 Feb;51(2):220-7. doi: 10.1203/00006450-200202000-00016.
6
Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages.表面活性蛋白D可刺激肺泡巨噬细胞对铜绿假单胞菌的吞噬作用。
Am J Respir Cell Mol Biol. 1999 Nov;21(5):576-85. doi: 10.1165/ajrcmb.21.5.3334.
7
Surfactant protein A stimulates phagocytosis of specific pulmonary pathogens by alveolar macrophages.表面活性蛋白A可刺激肺泡巨噬细胞对特定肺部病原体的吞噬作用。
Am J Physiol. 1996 Apr;270(4 Pt 1):L677-88. doi: 10.1152/ajplung.1996.270.4.L677.
8
Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages.肺表面活性物质蛋白A增强大鼠肺泡巨噬细胞的宿主防御机制。
Am J Respir Cell Mol Biol. 1990 Jan;2(1):91-8. doi: 10.1165/ajrcmb/2.1.91.
9
Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.肺表面活性蛋白A通过与人类巨噬细胞直接相互作用介导增强的结核分枝杆菌吞噬作用。
J Immunol. 1995 Dec 1;155(11):5343-51.
10
Surfactant protein-A reduces binding and phagocytosis of pneumocystis carinii by human alveolar macrophages in vitro.表面活性蛋白A在体外可降低人肺泡巨噬细胞对卡氏肺孢子虫的黏附和吞噬作用。
Am J Respir Cell Mol Biol. 1998 Jun;18(6):834-43. doi: 10.1165/ajrcmb.18.6.3059.

引用本文的文献

1
Surfactant Lipids at the Host-Environment Interface. Metabolic Sensors, Suppressors, and Effectors of Inflammatory Lung Disease.宿主-环境界面的表面活性脂质。炎症性肺病的代谢传感器、抑制剂和效应器。
Am J Respir Cell Mol Biol. 2016 May;54(5):624-35. doi: 10.1165/rcmb.2016-0011PS.